Grundlæggende statistik
| LEI | 549300YVNQPK8VJ8TT73 |
| CIK | 1680378 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to SenesTech, Inc.
SEC Filings (Chronological Order)
Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.
| June 3, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid |
|
| May 27, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid |
|
| May 13, 2026 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37941 SE |
|
| May 12, 2026 |
Exhibit 99.1 SenesTech Reports Record Direct-to-Consumer and Subscription Growth Following Strategic E-Commerce Transition In-house e-commerce transition and new CEO expected to support scalable recurring revenue growth strategy SURPRISE, Ariz., May 12, 2026 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer |
|
| May 12, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 12, 2026 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 7, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2026 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Number |
|
| May 7, 2026 |
Exhibit 10.1 May 6, 2026 Michael Edell Re: Employment Offer – Chief Executive Officer Dear Michael, SenesTech, Inc. (“SenesTech” or the “Company”) is pleased to offer you the position of Chief Executive Officer (“CEO”) on the terms of this letter agreement (the “Agreement”). Your start date as CEO (“Start Date”) will be the date of this Agreement. This offer is conditional and subject to your sati |
|
| May 7, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid |
|
| April 29, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid |
|
| April 29, 2026 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy |
|
| March 13, 2026 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37 |
|
| March 13, 2026 |
Exhibit 10.19 SenesTech, Inc. January 22, 2026 Joel Fruendt Via Email Re: Transition Agreement Dear Joel: This letter sets forth the substance of the agreement (the “Agreement”) that SenesTech, Inc. (the “Company”) is offering to you in view of your pending retirement. 1.Separation. If you timely sign this Agreement and allow the releases contained herein to become effective, then your employment |
|
| March 13, 2026 |
SUBSIDIARIES OF THE REGISTRANT Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT The following is a list of subsidiaries of the registrant as of December 31, 2025. Name Jurisdiction of incorporation or organization NONE |
|
| March 12, 2026 |
SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce Exhibit 99.1 SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce SURPRISE, Ariz., March 12, 2026. SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025. 2025 Highlights •Revenue increased by 20% to $2.2 million in 2025 as com |
|
| March 12, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 12, 2026 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Num |
|
| January 28, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 28, 2026 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File |
|
| January 28, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 22, 2026 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File N |
|
| November 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2025 SenesTech, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| November 14, 2025 |
Exhibit 10.1 11/3/25 Michael Edell Re: Employment Offer – Interim Chief Operating Officer Dear Michael, We are pleased to offer you the position of Interim Chief Operating Officer (“Interim COO”) with SenesTech, Inc. (the “Company”), reporting directly to the Chief Executive Officer, Joel Fruendt. Your employment will begin on November 3, 2025. This offer letter (“Letter Agreement”) sets forth the |
|
| November 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2025 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File |
|
| November 10, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-3794 |
|
| November 10, 2025 |
Exhibit 99.1 SenesTech Reports Third Quarter 2025 Financial Results with Record Revenue and Adjusted EBITDA 77% Revenue Growth in Evolve® Rodent Birth Control™ Products Strong Cash Balance and Progress Toward Profitability SURPRISE, Ariz., November 10, 2025 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer |
|
| October 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 15, 2025 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File N |
|
| September 24, 2025 |
SenesTech, Inc. Up to $7,580,675 of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-286955 PROSPECTUS SUPPLEMENT NO. 3 (to Prospectus dated June 24, 2025 and Prospectus Supplements dated June 24, 2025 and June 30, 2025) SenesTech, Inc. Up to $7,580,675 of Common Stock This prospectus supplement amends and supplements certain information in the prospectus supplement, dated June 24, 2025, as amended and supplemented by the prosp |
|
| September 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 24, 2025 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File |
|
| August 22, 2025 |
SenesTech, Inc. 2,261,252 Shares of Common Stock Filed Pursuant to Rule 424(b)(3) Registration No. 333-289650 PROSPECTUS SenesTech, Inc. 2,261,252 Shares of Common Stock Pursuant to this prospectus, the selling stockholders identified herein (the “Selling Stockholders”) are offering on a resale basis an aggregate of 2,188,308 shares (the “Inducement Shares”) of our common stock, par value $0.001 per share (“Common Stock”), representing shares is |
|
| August 20, 2025 |
SenesTech, Inc. 13430 North Dysart Road, Suite 105 Surprise, Arizona 85379 August 20, 2025 SenesTech, Inc. 13430 North Dysart Road, Suite 105 Surprise, Arizona 85379 August 20, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, DC 20549 Attention: Jane Park Re: SenesTech, Inc. Registration Statement on Form S-3 File No. 333-289650 Ladies and Gentlemen: In accordance with Rul |
|
| August 20, 2025 |
August 20, 2025 Joel Fruendt Chief Executive Officer SenesTech, Inc. 13430 North Dysart Road, Suite 105 Surprise, Arizona 85379 Re: SenesTech, Inc. Registration Statement on Form S-3 Filed August 15, 2025 File No. 333-289650 Dear Joel Fruendt: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for ac |
|
| August 15, 2025 |
Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-3 SenesTech, Inc. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Common Stock, par val |
|
| August 15, 2025 |
As filed with the Securities and Exchange Commission on August 15, 2025 As filed with the Securities and Exchange Commission on August 15, 2025 Registration No. |
|
| August 8, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37941 SEN |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 7, 2025 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Num |
|
| August 7, 2025 |
Exhibit 99.1 SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins 94% Revenue Growth in EvolveTM Rodent Birth Control Products Strong Cash Balance and Sustained Progress Toward Profitability SURPRISE, Ariz., August 7, 2025 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and th |
|
| August 5, 2025 |
Exhibit 10.1 SENESTECH, INC. August 4, 2025 Holder of Common Stock Purchase Warrants Issued in July 2025 Re: Inducement Offer to Exercise Common Stock Purchase Warrants Issued in July 2025 Dear Holder: SenesTech, Inc. (the “Company”) is pleased to offer to you (“Holder”, “you” or similar terminology) the opportunity to receive new warrants to purchase shares of the Company’s common stock, par valu |
|
| August 5, 2025 |
SenesTech Announces Warrant Exercise for $6.3 Million in Gross Proceeds Exhibit 99.1 SenesTech Announces Warrant Exercise for $6.3 Million in Gross Proceeds SURPRISE, Ariz., – August 5, 2025 – SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), a leader in fertility control for managing animal pest populations, announced today the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 1,458,872 |
|
| August 5, 2025 |
Form of Placement Agent Warrant Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| August 5, 2025 |
Form of Series I Common Stock Purchase Warrant Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| August 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 4, 2025 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Num |
|
| July 18, 2025 |
SenesTech, Inc. 1,531,816 Shares of Common Stock Filed Pursuant to Rule 424(b)(3) Registration No. 333-288638 PROSPECTUS SenesTech, Inc. 1,531,816 Shares of Common Stock Pursuant to this prospectus, the selling stockholders identified herein (the “Selling Stockholders”) are offering on a resale basis an aggregate of 1,458,872 shares (the “Inducement Shares”) of our common stock, par value $0.001 per share (“Common Stock”), representing shares is |
|
| July 16, 2025 |
July 16, 2025 Joel L. Fruendt President and Chief Executive Officer SenesTech, Inc. 13430 North Dysart Road, Suite 105 Surprise, AZ 85379 Re: SenesTech, Inc. Registration Statement on Form S-3 Filed July 11, 2025 File No. 333-288638 Dear Joel L. Fruendt: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requ |
|
| July 16, 2025 |
SenesTech, Inc. 13430 North Dysart Road, Suite 105 Surprise, Arizona 85379 July 16, 2025 SenesTech, Inc. 13430 North Dysart Road, Suite 105 Surprise, Arizona 85379 July 16, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, DC 20549 Attention: Margaret Sawicki Re: SenesTech, Inc. Registration Statement on Form S-3 File No. 333-288638 Ladies and Gentlemen: In accordance wit |
|
| July 11, 2025 |
As filed with the Securities and Exchange Commission on July 11, 2025 As filed with the Securities and Exchange Commission on July 11, 2025 Registration No. |
|
| July 11, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) SenesTech, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equity Common Stock, pa |
|
| July 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 5, 2025 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| July 1, 2025 |
Exhibit 10.1 SENESTECH, INC. June 30, 2025 Holder of Common Stock Purchase Warrants Issued in March 2025 Re: Inducement Offer to Exercise Common Stock Purchase Warrants Issued in March 2025 Dear Holder: SenesTech, Inc. (the “Company”) is pleased to offer to you (“Holder”, “you” or similar terminology) the opportunity to receive new warrants to purchase shares of the Company’s common stock, par val |
|
| July 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 30, 2025 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| July 1, 2025 |
Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| July 1, 2025 |
Form of Series H Common Stock Purchase Warrant Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| July 1, 2025 |
SenesTech Announces Warrant Exercise for $4.4 Million in Gross Proceeds Exhibit 99.1 SenesTech Announces Warrant Exercise for $4.4 Million in Gross Proceeds SURPRISE, Ariz., – July 1, 2025 – SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), a leader in fertility control for managing animal pest populations, announced today the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 1,458,872 s |
|
| June 30, 2025 |
SenesTech, Inc. Up to $711,227 of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-286955 PROSPECTUS SUPPLEMENT NO. 2 (to Prospectus dated June 24, 2025 and Prospectus Supplement dated June 24, 2025) SenesTech, Inc. Up to $711,227 of Common Stock This prospectus supplement amends and supplements the information in the prospectus supplement, dated June 24, 2025 (the “ATM Prospectus Supplement”), to the accompanying base prospe |
|
| June 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 30, 2025 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| June 25, 2025 |
SenesTech, Inc. 1,517,608 Shares of Common Stock Filed Pursuant to Rule 424(b)(3) Registration No. 333-288097 PROSPECTUS SenesTech, Inc. 1,517,608 Shares of Common Stock Pursuant to this prospectus, the selling stockholders identified herein (the “Selling Stockholders”) are offering on a resale basis an aggregate of 1,498,872 shares (the “Inducement Shares”) of our common stock, par value $0.001 per share (“Common Stock”), representing shares is |
|
| June 25, 2025 |
SenesTech, Inc. Up to $843,069 of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-286955 PROSPECTUS SUPPLEMENT (To Prospectus dated June 24, 2025) SenesTech, Inc. Up to $843,069 of Common Stock We have entered into an At The Market Offering Agreement (the “Sales Agreement”), dated June 20, 2024, with H.C. Wainwright & Co., LLC, as sales agent or principal (“Wainwright” or the “sales agent”), relating to the sale of shares of |
|
| June 23, 2025 |
June 23, 2025 Joel Fruendt Chief Executive Officer SenesTech, Inc. 13430 North Dysart Road, Suite 105 Surprise, AZ 85379 Re: SenesTech, Inc. Registration Statement on Form S-3 Filed June 17, 2025 File No. 333-288097 Dear Joel Fruendt: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleratio |
|
| June 23, 2025 |
As filed with the Securities and Exchange Commission on June 23, 2025 As filed with the Securities and Exchange Commission on June 23, 2025 Registration No. |
|
| June 23, 2025 |
SenesTech, Inc. 13430 North Dysart Road, Suite 105 Surprise, Arizona 85379 June 23, 2025 SenesTech, Inc. 13430 North Dysart Road, Suite 105 Surprise, Arizona 85379 June 23, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, DC 20549 Attention: Margaret Sawicki Re: SenesTech, Inc. Registration Statement on Form S-3 File No. 333-286955 Ladies and Gentlemen: In accordance wit |
|
| June 23, 2025 |
SenesTech, Inc. 13430 North Dysart Road, Suite 105 Surprise, Arizona 85379 June 23, 2025 SenesTech, Inc. 13430 North Dysart Road, Suite 105 Surprise, Arizona 85379 June 23, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, DC 20549 Attention: Juan Grana Re: SenesTech, Inc. Registration Statement on Form S-3 File No. 333-288097 Ladies and Gentlemen: In accordance with Rule |
|
| June 17, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) SenesTech, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equity Common Stock, pa |
|
| June 17, 2025 |
As filed with the Securities and Exchange Commission on June 16, 2025 As filed with the Securities and Exchange Commission on June 16, 2025 Registration No. |
|
| June 10, 2025 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 9, 2025 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 8, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2025 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Number |
|
| May 8, 2025 |
Exhibit 99.1 SenesTech Reports First Quarter 2025 Financial Results 40% Revenue Growth in EvolveTM, Record Gross Profit Margins of 65%, and Continued Progress Toward Profitability SURPRISE, Ariz., May 8, 2025. SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced |
|
| May 8, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37941 SE |
|
| May 7, 2025 |
May 7, 2025 Joel L. Fruendt President and Chief Executive Officer SenesTech, Inc. 13430 North Dysart Road, Suite 105 Surprise, Arizona 85379 Re: SenesTech, Inc. Registration Statement on Form S-3 Filed May 2, 2025 File No. 333-286955 Dear Joel L. Fruendt: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding req |
|
| May 2, 2025 |
As filed with the Securities and Exchange Commission on May 2, 2025 As filed with the Securities and Exchange Commission on May 2, 2025 Registration No. |
|
| May 2, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) SenesTech, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward For |
|
| April 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid |
|
| April 28, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy |
|
| April 22, 2025 |
SenesTech, Inc. Up to $743,489 of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-261227 PROSPECTUS SUPPLEMENT (to Prospectus dated May 6, 2022 and Prospectus Supplement dated June 20, 2024) SenesTech, Inc. Up to $743,489 of Common Stock This prospectus supplement amends and supplements the information in the prospectus supplement, dated June 20, 2024 (the “ATM Prospectus Supplement”), to the prospectus, dated May 6, 2022, r |
|
| April 18, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy |
|
| March 13, 2025 |
List of Subsidiaries of the Registrant. Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT The following is a list of subsidiaries of the registrant as of December 31, 2024. Name Jurisdiction of incorporation or organization NONE |
|
| March 13, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37 |
|
| March 13, 2025 |
INITIALS INITIALS © 2017 AIR CRE. All Rights Reserved. Last Edited: 8/9/2024 3:10 PM MTNAZ-15.00, Revised 10-22-2020 Page 1 of 17 1. Basic Provisions ("Basic Provisions"). 1.1 This Lease ("Lease"), dated for reference purposes only July 17, 2024 , is made by and between E&V Investments, LLC ("Lessor") and SenesTech, Inc ("Lessee"), the " ", or individually a "Party"). 1.2(a) Premises: That certain |
|
| March 13, 2025 |
enesTech, Inc. Insider Trading Policy Exhibit No. 19.1 SENESTECH, INC. Policy on Insider Trading (Revised April 24, 2017) This Insider Trading Policy provides the standards of SenesTech, Inc. (the “Company”) on trading and causing the trading of the Company’s securities or securities of other publicly-traded companies while in possession of confidential information. This policy is divided into two parts: the first part prohibits tradi |
|
| March 12, 2025 |
Exhibit 99.1 SenesTech Announces Record Fourth Quarter and Full Year 2024 Financial Results with 70% Quarterly Revenue Growth; Gross Profit Margins of 61%; Reduction in Operating Expenses; and Dramatic Improvement in Adjusted EBITDA Company announces new operating optimization initiatives to reduce expenses by approximately $2 million to accelerate path to profitability PHOENIX, Ariz., March 12, 2 |
|
| March 12, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 12, 2025 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Num |
|
| March 11, 2025 |
Exhibit 10.1 SENESTECH, INC. March 9, 2025 Holder of Common Stock Purchase Warrants Issued in August 2024 Re: Inducement Offer to Exercise Common Stock Purchase Warrants Issued in August 2024 Dear Holder: SenesTech, Inc. (the “Company”) is pleased to offer to you (“Holder”, “you” or similar terminology) the opportunity to receive (i) new warrants to purchase shares of the Company’s common stock, p |
|
| March 11, 2025 |
Form of Series G Common Stock Purchase Warrant Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| March 11, 2025 |
Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| March 11, 2025 |
SenesTech Announces Warrant Exercise for $1.1 Million in Gross Proceeds Exhibit 99.1 SenesTech Announces Warrant Exercise for $1.1 Million in Gross Proceeds PHOENIX, AZ – March 10, 2025 – SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in fertility control solutions for managing rodent populations, announced today the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 374,718 |
|
| March 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 9, 2025 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| February 14, 2025 |
Exhibit 99.1 JOINT FILING APPLICATION The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of SenesTech, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G. February 14, 2025 LIND GLOBAL FUND II LP By: Lind Global Partners II LLC it |
|
| January 10, 2025 |
Joshua M. Moss Joining the SenesTech Board of Directors Exhibit 99.1 Joshua M. Moss Joining the SenesTech Board of Directors PHOENIX, Ariz., January 10, 2025. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), a pioneer in humane pest control solutions, is pleased to announce that Joshua M. Moss will be joining the Board of Directors of SenesTech, Inc. Joshua M. Moss is the co-founder, Managing Director, and Portfolio Manager at EAM Global I |
|
| January 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 8, 2025 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 14, 2024 |
EX-99.1 2 exhibit99-1.htm JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of SenesTech, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedul |
|
| November 14, 2024 |
SNES / SenesTech, Inc. / Lind Global Fund II LP Passive Investment SC 13G/A 1 sch13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* SenesTech, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 81720R604 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box t |
|
| November 14, 2024 |
SNES / SenesTech, Inc. / Lind Global Macro Fund LP Passive Investment SC 13G/A 1 sch13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* SenesTech, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 81720R604 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box t |
|
| November 14, 2024 |
EX-99.1 2 exhibit99-1.htm JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of SenesTech, Inc.. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedu |
|
| November 12, 2024 |
SenesTech Announces Third Quarter 2024 Financial Results Record Revenue and Margin Performance Exhibit 99.1 SenesTech Announces Third Quarter 2024 Financial Results Record Revenue and Margin Performance PHOENIX, Ariz., November 12, 2024. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), the leader in fertility control to manage animal pest populations and the only manufacturer of commercial and consumer available EPA-registered Rat Birth Control® products today announced financi |
|
| November 12, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-3794 |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 12, 2024 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File |
|
| November 12, 2024 |
EX-99 2 p24-3327exhibit1.htm JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K) Exhibit 1 JOINT FILING AGREEMENT The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additio |
|
| November 12, 2024 |
SNES / SenesTech, Inc. / PFS CAP MGT CO Passive Investment SC 13G 1 p24-3327sc13g.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* SenesTech, Inc. (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 81720R604 (CUSIP Number) November 27, 2023 and December 31, 2023 (Date of Event Which Requires Filing of This Statement) Check the approp |
|
| October 4, 2024 |
SenesTech, Inc. 1,036,279 Shares of Common Stock PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-282286 SenesTech, Inc. 1,036,279 Shares of Common Stock Pursuant to this prospectus, the selling stockholders identified herein (the “Selling Stockholders”) are offering on a resale basis an aggregate of 1,011,004 shares (the “Shares”) of our common stock, par value $0.001 per share (“Common Stock”), representing Shares issuable upon |
|
| October 2, 2024 |
SenesTech, Inc. 23460 N. 19th Ave., Suite 110 Phoenix, Arizona 85027 October 2, 2024 SenesTech, Inc. 23460 N. 19th Ave., Suite 110 Phoenix, Arizona 85027 October 2, 2024 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F Street, N.E. Washington, DC 20549 Attention: Jane Park Re: SenesTech, Inc. Registration Statement on Form S-3 File No. 333-282286 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Ac |
|
| September 27, 2024 |
September 27, 2024 Joel Fruendt President and Chief Executive Officer SenesTech, Inc. |
|
| September 23, 2024 |
As filed with the Securities and Exchange Commission on September 23, 2024 As filed with the Securities and Exchange Commission on September 23, 2024 Registration No. |
|
| September 23, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) SenesTech, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equity Common Stock, pa |
|
| August 23, 2024 |
Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| August 23, 2024 |
Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| August 23, 2024 |
Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| August 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 22, 2024 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| August 23, 2024 |
Exhibit 10.1 SENESTECH, INC. August 22, 2024 Holder of Common Stock Purchase Warrants Issued in August 2023 and November 2023 Re: Inducement Offer to Exercise Common Stock Purchase Warrants Issued in August 2023 and November 2023 Dear Holder: SenesTech, Inc. (the “Company”) is pleased to offer to you (“Holder”, “you” or similar terminology) the opportunity to receive (i) new warrants to purchase s |
|
| August 8, 2024 |
SenesTech Announces Second Quarter 2024 Financial Results Record Revenue and Margin Performance Exhibit 99.1 SenesTech Announces Second Quarter 2024 Financial Results Record Revenue and Margin Performance PHOENIX, Ariz., August 8, 2024. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results f |
|
| August 8, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37941 SEN |
|
| August 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 8, 2024 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Num |
|
| August 6, 2024 |
As filed with the Securities and Exchange Commission on August 6, 2024 As filed with the Securities and Exchange Commission on August 6, 2024 Registration No. |
|
| August 6, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) SenesTech, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.001 p |
|
| August 5, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 31, 2024 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| July 23, 2024 |
Certificate of Amendment to Amended and Restated Certificate of Incorporation of SenesTech, Inc. Exhibit 3.1(a) CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SENESTECH, INC. SENESTECH, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify as follows: 1.The name of the Corporation is SenesTech, Inc. 2.The Board of Directors of the Corporation has duly adopted a resolution |
|
| July 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 23, 2024 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| July 23, 2024 |
Exhibit 99.1 SenesTech Announces Reverse Stock Split Common Stock Will Begin Trading on a Split-Adjusted Basis on July 25, 2024 PHOENIX, Ariz., July 23, 2024. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”) (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced that it intends to effect a reverse stock split of its common stock at a rati |
|
| July 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 11, 2024 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| July 15, 2024 |
centive Plan, as amended (Form 8-K filed July 15, 2024, Exhibit no. 10.1 (File no. 001-379 Exhibit 10.1 SENESTECH, INC. 2018 EQUITY INCENTIVE PLAN AS AMENDED 1. General. (a) Eligible Stock Award Recipients. Employees, Directors and Consultants are eligible to receive Stock Awards. (b) Available Stock Awards. The Plan provides for the grant of the following types of Stock Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock Options, (iii) Stock Appreciation Rights, (iv) Restricte |
|
| June 20, 2024 |
SenesTech, Inc. Up to $1,575,944 of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-261227 PROSPECTUS SUPPLEMENT (to Prospectus dated May 6, 2022) SenesTech, Inc. Up to $1,575,944 of Common Stock We have entered into an At The Market Offering Agreement (the “Sales Agreement”), dated June 20, 2024, with H.C. Wainwright & Co., LLC, as sales agent or principal (“Wainwright” or the “sales agent”), relating to the sale of shares of |
|
| June 20, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 20, 2024 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| June 20, 2024 |
Exhibit 1.1 AT THE MARKET OFFERING AGREEMENT June 20, 2024 H.C. Wainwright & Co., LLC 430 Park Avenue New York, New York 10022 Ladies and Gentlemen: SenesTech, Inc., a corporation organized under the laws of Delaware (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows: 1. Definitions. The terms that follow, when used in this Agreeme |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid |
|
| May 28, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy |
|
| May 15, 2024 |
SNES / SenesTech, Inc. / Lind Global Fund II LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* SenesTech, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 81720R505 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pu |
|
| May 15, 2024 |
EX-99.1 2 exhibit99-1.htm JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of SenesTech, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedul |
|
| May 14, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy |
|
| May 9, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2024 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Number |
|
| May 9, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37941 SE |
|
| May 9, 2024 |
SenesTech Announces First Quarter 2024 Financial Results Exhibit 99.1 SenesTech Announces First Quarter 2024 Financial Results PHOENIX, Ariz., May 9, 2024. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the first quarter of 2024. Recent Highl |
|
| May 1, 2024 |
Shareholder Director Nominations UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 26, 2024 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Num |
|
| April 29, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001- |
|
| April 29, 2024 |
SenesTech, Inc. Executive Officer Clawback Policy. Exhibit 97.1 SenesTech, Inc. Executive Officer Clawback Policy Approved by the Board of Directors on November 27, 2023 (the “Adoption Date”) I.Purpose This Executive Officer Clawback Policy describes the circumstances under which Covered Persons of SenesTech, Inc. and any of its direct or indirect subsidiaries (the “Company”) will be required to repay or return Erroneously-Awarded Compensation to |
|
| February 27, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 26, 2024 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File |
|
| February 21, 2024 |
List of Subsidiaries of the Registrant. Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT The following is a list of subsidiaries of the registrant as of December 31, 2023. Name Jurisdiction of incorporation or organization NONE |
|
| February 21, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37 |
|
| February 21, 2024 |
Exhibit 99.1 SenesTech Announces 2023 Financial Results YTD 2024 total revenue up more than 80% compared to YTD 2023 driven by orders for EvolveTM soft bait PHOENIX, Ariz., February 21, 2024. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced |
|
| February 21, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 21, 2024 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File |
|
| February 14, 2024 |
US81720R5054 / SENESTECH INC / ARMISTICE CAPITAL, LLC Passive Investment SC 13G/A 1 armistice-snes123123a1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* SENESTECH, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 81720R505 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo |
|
| February 13, 2024 |
EX-99.1 2 exhibit99-1.htm JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of SenesTech, Inc.. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedu |
|
| February 13, 2024 |
US81720R5054 / SENESTECH INC / Lind Global Fund II LP Passive Investment SC 13G/A 1 sch13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* SenesTech, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 81720R505 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to |
|
| November 29, 2023 |
SenesTech, Inc. Announces Closing of $5.0 Million Public Offering Exhibit 99.2 SenesTech, Inc. Announces Closing of $5.0 Million Public Offering PHOENIX, Ariz., November 29, 2023 – SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced the closing of its previously announced public offering of 3,846,154 shares of its common stock (or pre-funded warrants |
|
| November 29, 2023 |
Exhibit 4.34 SERIES D COMMON STOCK PURCHASE WARRANT senestech, inc. Warrant Shares: Issue Date: November 29, 2023 Initial Exercise Date: November 29, 2023 THIS SERIES D COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any |
|
| November 29, 2023 |
Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 27, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File |
|
| November 29, 2023 |
Exhibit 4.37 PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT senestech, inc. Warrant Shares: Issue Date: November 29, 2023 Initial Exercise Date: November 29, 2023 THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set |
|
| November 29, 2023 |
Exhibit 4.36 PRE-FUNDED COMMON STOCK PURCHASE WARRANT SENESTECH, INC. Warrant Shares: Issue Date: November 29, 2023 Initial Exercise Date: November 29, 2023 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at |
|
| November 29, 2023 |
Exhibit 10.28 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of November 27, 2023, between SenesTech, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHEREAS, subject to the terms and conditions set |
|
| November 29, 2023 |
SenesTech, Inc. Announces Pricing of $5.0 Million Public Offering Exhibit 99.1 SenesTech, Inc. Announces Pricing of $5.0 Million Public Offering PHOENIX, Ariz., November 27, 2023 – SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced the pricing of a public offering of 3,846,154 shares of its common stock (or pre-funded warrants in lieu thereof) and ac |
|
| November 29, 2023 |
PROSPECTUS Filed Pursuant to Rule 424(b)(4) Registration No. 333-273370 SenesTech, Inc. 450,306 Shares of Common Stock and Accompanying Series D Warrants to Purchase up to 450,306 Shares of Common Stock and Series E Warrants to Purchase up to 450,306 Shares of Common Stock Pre-Funded Warrants to Purchase up to 3,395,848 Shares of Common Stock and Accompanying Series D Warrants to Purchase up to 3, |
|
| November 29, 2023 |
Exhibit 4.35 SERIES E COMMON STOCK PURCHASE WARRANT senestech, inc. Warrant Shares: Issue Date: November 29, 2023 Initial Exercise Date: November 29, 2023 THIS SERIES E COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any |
|
| November 27, 2023 |
As filed with the Securities and Exchange Commission on November 27, 2023 As filed with the Securities and Exchange Commission on November 27, 2023 Registration No. |
|
| November 27, 2023 |
SenesTech, Inc. 23460 N. 19th Ave., Suite 110 Phoenix, Arizona 85027 November 27, 2023 SenesTech, Inc. 23460 N. 19th Ave., Suite 110 Phoenix, Arizona 85027 November 27, 2023 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Washington, DC 20549 Attention: Jessica Ansart Re: SenesTech, Inc. Registration Statement on Form S-1, as amended File No. 333-273370 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, S |
|
| November 27, 2023 |
November 27, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance Washington, DC 20549 Re: SenesTech, Inc. Registration Statement on Form S-1 (Registration No. 333-273370), as amended - Concurrence in Acceleration Request Ladies and Gentlemen: H.C. Wainwright & Co., LLC (“Wainwright”), solely acting as placement agent on a best efforts basis in an offering pursuant |
|
| November 22, 2023 |
Exhibit 4.30 SERIES D COMMON STOCK PURCHASE WARRANT senestech, inc. Warrant Shares: Issue Date: , 2023 Initial Exercise Date: , 2023 THIS SERIES D COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the |
|
| November 22, 2023 |
Form of Securities Purchase Agreement Exhibit 10.27 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of [], 2023, between SenesTech, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHEREAS, subject to the terms and conditions set forth in |
|
| November 22, 2023 |
Exhibit 4.31 SERIES E COMMON STOCK PURCHASE WARRANT senestech, inc. Warrant Shares: Issue Date:, 2023 Initial Exercise Date: , 2023 THIS SERIES E COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the e |
|
| November 22, 2023 |
As filed with the Securities and Exchange Commission on November 22, 2023 As filed with the Securities and Exchange Commission on November 22, 2023 Registration No. |
|
| November 22, 2023 |
Form of Placement Agent Warrant Exhibit 4.33 PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT senestech, inc. Warrant Shares: Issue Date: , 2023 Initial Exercise Date: , 2023 THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on |
|
| November 22, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 20, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File |
|
| November 22, 2023 |
Exhibit 4.32 PRE-FUNDED COMMON STOCK PURCHASE WARRANT SENESTECH, INC. Warrant Shares: Issue Date:, 2023 Initial Exercise Date: , 2023 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after t |
|
| November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 14, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File |
|
| November 15, 2023 |
Exhibit 3.1(a) CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SENESTECH, INC. SENESTECH, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify as follows: 1.The name of the Corporation is SenesTech, Inc. 2.The Board of Directors of the Corporation has duly adopted a resolution |
|
| November 15, 2023 |
Exhibit 99.1 SenesTech Announces Reverse Stock Split Common Stock Will Begin Trading on a Split-Adjusted Basis on November 17, 2023 PHOENIX, Ariz., November 15, 2023. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”) (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced that it intends to effect a reverse stock split of its common stock a |
|
| November 9, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File N |
|
| November 9, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-3794 |
|
| November 9, 2023 |
Exhibit 99.1 SenesTech Announces Third Quarter 2023 Financial Results Revenue Growth Up 44%; Net Loss Improved by Almost $700,000 Company to Begin Shipments of Evolve Soft Bait Next Week Expected to Be a Key Driver of Revenue Growth PHOENIX, Ariz., November 9, 2023. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), (www.senestech.com) the leader in fertility control to manage animal pe |
|
| October 17, 2023 |
SenesTech, Inc. 6,015,879 Shares of Common Stock PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-274894 SenesTech, Inc. 6,015,879 Shares of Common Stock Pursuant to this prospectus, the selling stockholders identified herein (the “Selling Stockholders”) are offering on a resale basis an aggregate of 6,015,879 shares (the “Shares”) of our common stock, par value $0.001 per share (“Common Stock”), representing Shares issuable upon |
|
| October 13, 2023 |
SenesTech, Inc. 23460 N. 19th Ave., Suite 110 Phoenix, Arizona 85027 October 13, 2023 SenesTech, Inc. 23460 N. 19th Ave., Suite 110 Phoenix, Arizona 85027 October 13, 2023 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, DC 20549 Attention: Juan Grana Re: SenesTech, Inc. Registration Statement on Form S-3 File No. 333-274894 Ladies and Gentlemen: In accordance with Rule 46 |
|
| October 13, 2023 |
United States securities and exchange commission logo October 13, 2023 Joel L. Fruendt President and Chief Executive Officer SenesTech, Inc. 23460 N. 19th Ave., Suite 110 Phoenix, Arizona 85027 Re: SenesTech, Inc. Registration Statement on Form S-3 Filed October 6, 2023 File No. 333-274894 Dear Joel L. Fruendt: This is to advise you that we have not reviewed and will not review your registration s |
|
| October 6, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) SenesTech, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equity Common Stock, p |
|
| October 6, 2023 |
As filed with the Securities and Exchange Commission on October 6, 2023 As filed with the Securities and Exchange Commission on October 6, 2023 Registration No. |
|
| September 26, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) SenesTech, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.001 |
|
| September 26, 2023 |
As filed with the Securities and Exchange Commission on September 26, 2023 As filed with the Securities and Exchange Commission on September 26, 2023 Registration No. |
|
| August 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 25, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| August 22, 2023 |
Exhibit 4.33 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST |
|
| August 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 21, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| August 22, 2023 |
Form of Inducement Letter (Form 8-K filed August 22, 2023, Exhibit 10.29 (File no. 001-37941)). Exhibit 10.29 SENESTECH, INC. August 21, 2023 Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder: SenesTech, Inc. (the “Company”) is pleased to offer to you (“Holder”, “you” or similar terminology) the opportunity to receive (i) new warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common St |
|
| August 21, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 18, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| August 11, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37941 SEN |
|
| August 10, 2023 |
Exhibit 99.1 SenesTech Announces Second Quarter 2023 Financial Results July 2023 Sales Increased 126% as New Initiatives Take Hold Expanded Product Offerings Expected to Drive Future Growth PHOENIX, Ariz., August 10, 2023. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 10, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| July 31, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy |
|
| July 31, 2023 |
United States securities and exchange commission logo July 31, 2023 Joel Fruendt President and Chief Executive Officer SenesTech, Inc. |
|
| July 21, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy |
|
| July 21, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) SenesTech, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Masimum Aggregate Offering Price (1) Fee Rate Amount of Registration Fee Fee |
|
| July 21, 2023 |
As filed with the Securities and Exchange Commission on July 21, 2023 As filed with the Securities and Exchange Commission on July 21, 2023 Registration No. |
|
| June 27, 2023 |
Exhibit 10.28 SENESTECH, INC. 2018 EQUITY INCENTIVE PLAN AS AMENDED 1. General. (a) Eligible Stock Award Recipients. Employees, Directors and Consultants are eligible to receive Stock Awards. (b) Available Stock Awards. The Plan provides for the grant of the following types of Stock Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock Options, (iii) Stock Appreciation Rights, (iv) Restrict |
|
| June 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 26, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 11, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 11, 2023 |
SenesTech Announces First Quarter 2023 Financial Results E-Commerce Leads Growth at 54% Year Over Year PHOENIX, Ariz. |
|
| May 11, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37941 SE |
|
| April 28, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULED 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid |
|
| April 24, 2023 |
Exhibit 10.27 EXECUTION VERSION April 20, 2023 Nicole Williams Via Email Delivery Dear Nicole, This letter sets forth the substance of the separation agreement (the “Agreement”) that SenesTech (the “Company”) is offering to you as appreciation for your contributions, and to aid in your employment transition. 1.End of Employment The Company has decided to end your employment due to missing revenue |
|
| April 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 20, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Num |
|
| April 19, 2023 |
US81720R4065 / SENESTECH INC / INTRACOASTAL CAPITAL, LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* SenesTech, Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 81720R406 (CUSIP Number) April 10, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua |
|
| April 19, 2023 |
Exhibit 1 JOINT FILING AGREEMENT The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. |
|
| April 17, 2023 |
US81720R4065 / SENESTECH INC / Lind Global Fund II LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* SenesTech, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 81720R406 (CUSIP Number) April 12, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua |
|
| April 17, 2023 |
EX-99.1 2 exhibit99-1.htm JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.001 per share, of SenesTech, Inc., shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedu |
|
| April 12, 2023 |
SenesTech Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Exhibit 99.1 SenesTech Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules PHOENIX, Ariz., April 10, 2023 – SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”) (www.senestech.com), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced that it has entered into |
|
| April 12, 2023 |
Exhibit 10.26 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of April 10, 2023, between SenesTech, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHEREAS, subject to the terms and conditions set fo |
|
| April 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 10, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Num |
|
| April 12, 2023 |
Exhibit 4.29 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST |
|
| April 12, 2023 |
Exhibit 99.2 SenesTech Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules PHOENIX, Ariz., April 12, 2023 – SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”) (www.senestech.com), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the closing of |
|
| April 12, 2023 |
SenesTech, Inc. 857,146 Shares of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-261227 PROSPECTUS SUPPLEMENT (to Prospectus dated May 6, 2022) SenesTech, Inc. 857,146 Shares of Common Stock We are offering 857,146 shares of our common stock, par value $0.001 per share (“Common Stock”), to certain investors pursuant to this prospectus supplement and the accompanying prospectus. Such investors will also receive unregistered |
|
| April 12, 2023 |
Exhibit 4.28 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST |
|
| March 17, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37 |
|
| March 17, 2023 |
List of Subsidiaries of the Registrant. EX-21.1 2 snes-20221231xex211.htm EX-21.1 Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT The following is a list of subsidiaries of the registrant as of December 31, 2022. Name Jurisdiction of incorporation or organization NONE |
|
| March 16, 2023 |
Exhibit 99.1 SenesTech Announces 2022 Financial Results Product Sales Break $1 Million Sales Increase 77% for the Year PHOENIX, Ariz., March 16, 2023. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced 2022 financial resul |
|
| March 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 16, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Num |
|
| February 16, 2023 |
SenesTech Names Nicole Williams as Chief Revenue Officer Exhibit 99.1 SenesTech Names Nicole Williams as Chief Revenue Officer PHOENIX, Ariz., February 16, 2023. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the appointment of Nicole Williams as Chief Revenue Officer. Ms. Wi |
|
| February 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2023 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File |
|
| February 14, 2023 |
US81720R4065 / SENESTECH INC / ARMISTICE CAPITAL, LLC Passive Investment SC 13G 1 armistice-snes123122.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* SENESTECH, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 81720R406 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| February 10, 2023 |
As filed with the Securities and Exchange Commission on February 10, 2023 As filed with the Securities and Exchange Commission on February 10, 2023 Registration No. |
|
| February 10, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) SenesTech, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.001 |
|
| February 10, 2023 |
Exhibit 4.3 SENESTECH, INC. FORM OF RESTRICTED STOCK UNIT GRANT NOTICE Senestech, Inc. (the “Company”), hereby grants to you (“Grantee”) a Restricted Stock Unit Award for the number of Restricted Stock Units (the “Restricted Stock Units”) set forth below. Each Restricted Stock Unit represents the right to receive one share of Common Stock, subject to the terms and conditions set forth herein. The |
|
| February 10, 2023 |
Exhibit 4.2 SENESTECH, INC. FORM OF STOCK OPTION GRANT NOTICE Senestech, Inc. (the “Company”), hereby grants to Optionholder an option to purchase the number of shares of the Company’s Common Stock set forth below. This option is subject to all of the terms and conditions as set forth in this notice, in the Option Agreement and the Notice of Exercise, all of which are attached hereto and incorpora |
|
| January 5, 2023 |
SNES / SenesTech Inc / Sandpiper Capital - SENESTECH 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20 SCHEDULE13G Under the Securities Exchange Act of 1934 (Amendment No.)* SenesTech Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 80720R208 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fi |
|
| January 5, 2023 |
Exhibit 10.25 EXECUTION VERSION December 29, 2022 Kenneth Siegel Via Email Delivery Re: Separation Agreement Dear Ken: This letter sets forth the separation agreement (the ?Agreement?) that SenesTech, Inc. (the ?Company?) is offering to you to aid in your employment transition. 1. SEPARATION DATE. Your last day of employment with the Company was November 15, 2022 (the ?Separation Date?). The Compa |
|
| January 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 29, 2022 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File |
|
| December 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2022 SenesTech, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-37941 20-2079805 (State or other jurisdiction (Commission File Number) (IRS Employer |
|
| December 20, 2022 |
SenesTech Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Exhibit 99.1 SenesTech Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PHOENIX, Ariz., December 20, 2022 SenesTech, Inc. (NASDAQ: SNES, ?SenesTech? or the ?Company?), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest?, today reported the grant of inducement equity awards outside of the |
|
| November 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 16, 2022 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File |
|
| November 21, 2022 |
SenesTech, Inc. Announces Pricing of $5 Million Public Offering Exhibit 99.1 SenesTech, Inc. Announces Pricing of $5 Million Public Offering PHOENIX, Ariz., November 16, 2022 – SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the pricing of a public offering of up to 1,428,572 shares |
|
| November 21, 2022 |
SenesTech, Inc. Announces Closing of $5 Million Public Offering Exhibit 99.2 SenesTech, Inc. Announces Closing of $5 Million Public Offering PHOENIX, Ariz., November 18, 2022 – SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the closing of its previously announced public offering of |
|
| November 18, 2022 |
PROSPECTUS Filed Pursuant to Rule 424(b)(4) Registration No. 333-267991 SenesTech, Inc. 67,572 Shares of Common Stock and Accompanying Series A Warrants to Purchase 67,572 Shares of Common Stock and Series B Warrants to Purchase 67,572 Shares of Common Stock Pre-Funded Warrants to Purchase 1,361,000 Shares of Common Stock and Accompanying Series A Warrants to Purchase 1,361,000 Shares of Common St |
|
| November 15, 2022 |
As filed with the Securities and Exchange Commission on November 15, 2022 As filed with the Securities and Exchange Commission on November 15, 2022 Registration No. |
|
| November 15, 2022 |
SenesTech, Inc. 23460 N. 19th Ave., Suite 110 Phoenix, Arizona 85027 November 15, 2022 CORRESP 1 filename1.htm SenesTech, Inc. 23460 N. 19th Ave., Suite 110 Phoenix, Arizona 85027 November 15, 2022 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F Street, N.E. Washington, DC 20549 Attention: Jane Park Re: SenesTech, Inc. Registration Statement on Form S-1 File No. 333-267991 Ladies and Gentlemen: In accordance with Rule 4 |
|
| November 15, 2022 |
EX-4.21 2 fs12022a1ex4-21senestech.htm FORM OF SERIES A WARRANT Exhibit 4.21 SERIES A COMMON STOCK PURCHASE WARRANT senestech, inc. Warrant Shares: Issue Date:, 2022 Initial Exercise Date: , 2022 THIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the |
|
| November 15, 2022 |
Exhibit 4.23 PRE-FUNDED COMMON STOCK PURCHASE WARRANT SENESTECH, INC. Warrant Shares: Issue Date:, 2022 Initial Exercise Date: , 2022 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after t |
|
| November 15, 2022 |
Exhibit 99.1 SenesTech Announces Reverse Stock Split Common Stock Will Begin Trading on a Split-Adjusted Basis on November 16, 2022 PHOENIX, Ariz., November 15, 2022 SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced that i |
|
| November 15, 2022 |
November 15, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance Washington, DC 20549 Re: SenesTech, Inc. Registration Statement on Form S-1 (Registration No. 333-267991), as amended - Concurrence in Acceleration Request Ladies and Gentlemen: H.C. Wainwright & Co., LLC (?Wainwright?), solely acting as placement agent on a best efforts basis in an offering pursuant |
|
| November 15, 2022 |
Exhibit 3.1(a) CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SENESTECH, INC. SENESTECH, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify as follows: 1. The name of the Corporation is SenesTech, Inc. 2. The Board of Directors of the Corporation has duly adopted a resoluti |
|
| November 15, 2022 |
Exhibit 10.18 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of [], 2022, between SenesTech, Inc., a Delaware corporation (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively the ?Purchasers?). WHEREAS, subject to the terms and conditions set forth in |
|
| November 15, 2022 |
Exhibit 4.22 SERIES B COMMON STOCK PURCHASE WARRANT senestech, inc. Warrant Shares: Issue Date:, 2022 Initial Exercise Date: , 2022 THIS SERIES B COMMON STOCK PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the d |
|
| November 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 15, 2022 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File |
|
| November 15, 2022 |
Exhibit 4.24 PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT senestech, inc. Warrant Shares: Issue Date:, 2022 Initial Exercise Date: , 2022 THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on |
|
| November 14, 2022 |
Exhibit 10.24 SenesTech, Inc. 23460 N. 19th Avenue, Suite 110 Phoenix, AZ 85027 November 9, 2022 Joel Fruendt Via Email Re: Employment Terms Dear Joel: SenesTech, Inc. (the “Company”) is pleased to offer you employment in the position of Chief Executive Officer on the terms of this letter agreement (the “Agreement”). Your employment start date (“Start Date”) will be November 15, 2022. 1. Duties an |
|
| November 14, 2022 |
Exhibit 99.2 SenesTech Announces Appointment of Vector and Pest Control Industry Veteran Joel Fruendt as Chief Executive Officer PHOENIX, Ariz., November 14, 2022. SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the app |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2022 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File N |
|
| November 14, 2022 |
SenesTech Announces Third Quarter 2022 Financial Results Product Sales up 57% year-over-year Exhibit 99.1 SenesTech Announces Third Quarter 2022 Financial Results Product Sales up 57% year-over-year PHOENIX, Ariz., November 14, 2022 SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced third quarter 2022 financial re |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37941 SENESTECH, INC. |
|
| October 31, 2022 |
United States securities and exchange commission logo October 31, 2022 Kenneth Siegel Chief Executive Officer SenesTech, Inc. |
|
| October 24, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) SenesTech, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Masimum Aggregate Offering Price (1) Fee Rate Amount of Registration Fee Fee |
|
| October 24, 2022 |
As filed with the Securities and Exchange Commission on October 24, 2022 Registration No. |
|
| October 14, 2022 |
Exhibit 10.23A SENESTECH, INC. 2018 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE Senestech, Inc. (the ?Company?), pursuant to its 2018 Equity Incentive Plan (the ?Plan?), hereby grants to you (?Optionholder?) an option to purchase the number of shares of the Company?s Common Stock set forth below. This option is subject to all of the terms and conditions as set forth in this Stock Option Grant |
|
| October 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 12, 2022 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File N |
|
| October 14, 2022 |
Exhibit 10.23 SENESTECH, INC. 2018 EQUITY INCENTIVE PLAN AS AMENDED 1. General. (a) Eligible Stock Award Recipients. Employees, Directors and Consultants are eligible to receive Stock Awards. (b) Available Stock Awards. The Plan provides for the grant of the following types of Stock Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock Options, (iii) Stock Appreciation Rights, (iv) Restrict |
|
| October 14, 2022 |
Exhibit 10.23B SENESTECH, INC. 2018 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT GRANT NOTICE Senestech, Inc. (the ?Company?), pursuant to its 2018 Equity Incentive Plan (the ?Plan?), hereby grants to you (?Grantee?) a Restricted Stock Unit Award for the number of Restricted Stock Units (the ?Restricted Stock Units?) set forth below. Each Restricted Stock Unit represents the right to receive one sh |
|
| September 12, 2022 |
DEF 14A 1 def14a0922senestech.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check |
|
| September 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 30, 2022 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| August 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 26, 2022 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37941 20-2079805 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| August 26, 2022 |
Exhibit 3.1 SENESTECH, INC. CERTIFICATE OF DESIGNATION OF SERIES C PREFERRED STOCK Pursuant to Section 151 of the General Corporation Law of the State of Delaware THE UNDERSIGNED DOES HEREBY CERTIFY, on behalf of SenesTech, Inc., a Delaware corporation (the ?Corporation?), that the following resolution was duly adopted by the board of directors of the Corporation (the ?Board of Directors?), in acc |
|
| August 26, 2022 |
Exhibit 99.1 SenesTech Announces Distribution of Series C Preferred Stock to Holders of its Common Stock Intended to Facilitate a Reverse Stock Split, if Necessary PHOENIX, Ariz., August 26, 2022 SenesTech, Inc. (NASDAQ: SNES, ?SenesTech? or the ?Company?) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, Contr |
|
| August 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 SenesTech, Inc. (Exact name of registrant as specified in its charter) Delaware 20-2079805 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 23460 N |
